Juan Corral-Pérez

Prof. Juan Corral-Pérez

University of Cádiz
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
AGAdrian Montes de Oca García
Adrian Montes de Oca García
APAlejandro Perez-Bey
Alejandro Perez-Bey
Daniel Velázquez-DíazDaniel Velázquez-Díaz
Daniel Velázquez-Díaz
Juan Corral-PérezJuan Corral-Pérez
Juan Corral-Pérez
EOEdgardo Opazo-Diaz
Edgardo Opazo-Diaz
Jesús Ponce GonzálezJesús Ponce González
Jesús Ponce González
There is controversy about the relationship between ACE I/D polymorphism and health. Seventy-four healthy adults (n = 28 women; 22.5 ± 4.2 years) participated in this cross-sectional study aimed at determining the influence of ACE I/D polymorphism, ascertained by polymerase chain reaction, on cardiometabolic risk (i.e., waist circumference, body fat, blood pressure (BP), glucose, triglycerides, and inflammatory markers), maximal fat oxidation (MFO), cardiorespiratory fitness (maximal oxygen uptake), physical activity and diet. Our results showed differences by ACE I/D polymorphism in systolic BP (DD: 116.4 ± 11.8 mmHg; ID: 116.7 ± 6.3 mmHg; II: 109.4 ± 12.3 mmHg, p = 0.035) and body fat (DD: 27.3 ± 10.8%; ID: 22.6 ± 9.7%; II: 19.3 ± 7.1%, p = 0.030). Interestingly, a genotype*sex interaction in relativized MFO by lean mass (p = 0.048) was found. The DD polymorphism had higher MFO values than ID/II polymorphisms in men (8.4 ± 3.0 vs. 6.5 ± 2.9 mg/kg/min), while the ID/II polymorphisms showed higher R-MFO values than DD polymorphism in women (6.6 ± 2.3 vs. 7.6 ± 2.6 mg/kg/min). In conclusion, ACE I/D polymorphism is apparently associated with adiposity and BP, where a protective effect can be attributed to the II genotype, but not with cardiorespiratory fitness, diet and physical activity. Moreover, our study highlighted that there is a sexual dimorphism in the influence of ACE I/D gene polymorphism on MFO.

5 November 2019 in Obesity
Verified
Journal Article
Open access
PDF file
David Jiménez PavónDavid Jiménez Pavón
David Jiménez Pavón
Juan Corral-PérezJuan Corral-Pérez
Juan Corral-Pérez
DSDavid Sanchez-Infantes
David Sanchez-Infantes
FVFrancesc Villarroya
Francesc Villarroya
Jonatan RuizJonatan Ruiz
Jonatan Ruiz
Borja Martínez-TéllezBorja Martínez-Téllez
Borja Martínez-Téllez
Objective: Brown adipose tissue (BAT) is a thermogenic tissue with potential as a therapeutic target in the treatment of obesity and related metabolic disorders. The most used technique for quantifying human BAT activity is the measurement of 18F‐fluorodeoxyglucose uptake via a positron emission tomography/computed tomography scan following exposure to cold. However, several studies have indicated the measurement of the supraclavicular skin temperature (SST) by infrared thermography (IRT) to be a less invasive alternative. This work reviews the state of the art of this latter method as a means of determining BAT activity in humans.Methods: The data sources for this review were PubMed, Web of Science, and EBSCOhost (SPORTdiscus), and eligible studies were those conducted in humans.Results: In most studies in which participants were first cooled, an increase in IRT‐measured SST was noted. However, only 5 of 24 such studies also involved a nuclear technique that confirmed increased activity in BAT, and only 2 took into account the thickness of the fat layer when measuring SST by IRT.Conclusions: More work is needed to understand the involvement of tissues other than BAT in determining IRT‐measured SST; at present, IRT cannot determine whether any increase in SST is due to increased BAT activity.

11 February 2021 in Frontiers in Physiology
Verified
Journal Article
Open access
Francisco J. Amaro-GaheteFrancisco J. Amaro-Gahete
Francisco J. Amaro-Gahete
JPJesús G. Ponce-González
Jesús G. Ponce-González
Juan Corral-PérezJuan Corral-Pérez
Juan Corral-Pérez
Daniel Velázquez-DíazDaniel Velázquez-Díaz
Daniel Velázquez-Díaz
CLCarl J. Lavie
Carl J. Lavie
David Jiménez PavónDavid Jiménez Pavón
David Jiménez Pavón
The present study aimed to investigate the effects of a 12-week concurrent training intervention on cardiometabolic health in obese men. Twelve obese men (42.5 ± 5.3 years old) participated in the current 12−week randomized controlled trial with a parallel group design. The participants were randomly assigned to a concurrent training group or to a no-exercise control group. Anthropometry and body composition assessment were determined by electrical bio-impedance. Blood samples were obtained and a cardiometabolic risk Z-Score was calculated. Energy metabolism-related parameters [i.e., resting metabolic rate (RMR), respiratory quotient (RQ), and substrate oxidation in both resting conditions and during exercise] were determined by indirect calorimetry. Echocardiographic studies were performed using an ultrasound system equipped with a transducer to measure cardiac function. A significant decrease of weight (Δ = −4.21 kg; i.e., primary outcome), body mass index (Δ = −1.32 kg/m2), fat mass (FM; Δ = −3.27 kg), blood pressure (BP; Δ = −10.81 mmHg), and cardiometabolic risk Z-Score (Δ = −0.39) was observed in the exercise group compared with the control group (allP< 0.05), while no significant changes were noted in waist circumference (WC), lean mass (LM), bone mineral content, glycemic and lipid profiles, liver function, nor in energy metabolism-related parameters (allP> 0.1). Moreover, a significant increment of left ventricular (LV) end diastolic diameter (Δ = −4.35 mm) was observed in the exercise group compared with the control group (P= 0.02). A 12-week concurrent training intervention is an effective strategy to induce weight and fat loss with simultaneous reductions of BP and cardiometabolic risk, and improving cardiac function in obese men.

23 April 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
Jesús Ponce GonzálezJesús Ponce González
Jesús Ponce González
ÁMÁngel Martínez-Ávila
Ángel Martínez-Ávila
Daniel Velázquez-DíazDaniel Velázquez-Díaz
Daniel Velázquez-Díaz
APAlejandro Perez-Bey
Alejandro Perez-Bey
FGFelix Gómez Gallego
Felix Gómez Gallego
Cristina CasalsCristina Casals
Cristina Casals
The FTO rs9939609 gene, which presents three polymorphisms (AA, AT, and TT), has been associated with the development of obesity through an increased fat accumulation; however, the associations of the gene with other physiological mechanisms, such as appetite or fat oxidation, are still unclear. Therefore, this study aims to evaluate the influence of the FTO rs9939609 gene on different obesity-related factors in young adults. The FTO rs9939609 polymorphism was genotyped in 73 participants (28 women, 22.27 ± 3.70 years). Obesity-related factors included dietary assessment, physical activity expenditure, body composition, appetite sensation, resting metabolic rate, maximal fat oxidation during exercise (MFO), and cardiorespiratory fitness. Our results showed that TT allele participants expressed higher values of hunger (p = 0.049) and appetite (p = 0.043) after exercising compared to the AT allele group. Moreover, the TT allele group showed significantly higher values of MFO (p = 0.031) compared to the AT group, regardless of sex and body mass index. Thus, our results suggest that the FTO rs9939609 gene has an influence on appetite, hunger, and fat oxidation during exercise, with TT allele participants showing significantly higher values compared to the AT allele group. These findings may have practical applications for weight loss and exercise programs.

1 February 2020 in Endocrinología, Diabetes y Nutrición
Verified
Journal Article
Closed access
MRMaría Rebollo-Ramos
María Rebollo-Ramos
DVDaniel Velázquez-Díaz
Daniel Velázquez-Díaz
Juan Corral-PérezJuan Corral-Pérez
Juan Corral-Pérez
ABAndré Barany
André Barany
APAlejandro Perez-Bey
Alejandro Perez-Bey
MCMagdalena Cuenca-García
Magdalena Cuenca-García

6 August 2020 in European Journal of Sport Science
Verified
Journal Article
Closed access
AGAdrian Montes de Oca García
Adrian Montes de Oca García
APAlejandro Perez-Bey
Alejandro Perez-Bey
Juan Corral-PérezJuan Corral-Pérez
Juan Corral-Pérez
Daniel Velázquez-DíazDaniel Velázquez-Díaz
Daniel Velázquez-Díaz
EOEdgardo Opazo-Diaz
Edgardo Opazo-Diaz
Jesús Ponce GonzálezJesús Ponce González
Jesús Ponce González
It is unknown whether resting fat oxidation (RFO), maximal fat oxidation (MFO) and FatMax (intensity at which MFO is reached) are related to cardiometabolic risk (CMR). Thus the aim of this study was to examine the association of RFO, MFO and FatMax with CMR. 81 healthy adults (n = 31 women; 22.72 ± 4.40 years) participated in this cross‐sectional study. Glucose and triglycerides were analysed in plasma. Body composition, anthropometry, physical activity, blood pressure (BP) and heart rate measurements were taken. RFO and MFO were determined through indirect calorimetry. Maximal oxygen uptake (VO2max) test was performed until exhaustion after MFO test. The CMR cluster was created from individual CMR factors: waist circumference, body fat percentage, systolic BP, diastolic BP, blood glucose and plasma triglycerides. Groups of high and low MFO and VO2max were created. RFO was not associated with CMR (p < 0.05). FatMax, MFO and VO2max were associated with individual CMR factors as waist circumference (R 2 = 0.144; R 2 = 0.241; R 2 = 0.285; p = 0.001; respectively) and plasma triglycerides (R 2 = 0.111; p = 0.004 and R 2 = 0.130; p = 0.002 and R 2 = 0.093; p = 0.008; respectively) and clustered CMR factors (R 2 = 0.105; p = 0.008 and R 2 = 0.162; p = 0.001 and R 2 = 0.239; p = 0.001; respectively). VO2max was also associated with body fat percentage (R 2 = 0.105; p = 0.003) and diastolic BP (R 2 = 0.083; p = 0.01), even adjusting for sex or age (p < 0.05). Groups with high level of MFO or VO2max obtained lower CMR (p = 0.001), even adjusting for sex or age (p < 0.01). FatMax, MFO and, especially, VO2max are associated with CMR, regardless of age and sex. However, RFO is not associated with CMR.